EMA lists rare spinal condition as side effect of AstraZeneca's Covid-19 vaccine

Share on facebook
Share on twitter
Share on email
Share on whatsapp

A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca’s Covid-19 vaccine.

© New Straits Times Press (M) Bhd